The Aryl Hydrocarbon Receptor in Anticancer Drug Discovery: Friend or Foe?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|8|27|2475-2490

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.8, Iss.27, 2002-12, pp. : 2475-2490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update to: The Aryl Hydrocarbon Receptor in Anticancer Drug Discovery: Friend or Foe?

By  

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 2, 2005-01 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

Role of the aryl hydrocarbon receptor in drug metabolism

By Ramadoss Preeti   Marcus Craig   Perdew Gary H  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 1, 2005-06 ,pp. : 9-21

Informa Healthcare

Access to resources Recommend Favorite

AMPK as a Potential Anticancer Target - Friend or Foe?

By  

Current Pharmaceutical Design, Vol. 20, Iss. 15, 2014-05 ,pp. : 2607-2618

Bentham Science Publishers

Access to resources Recommend Favorite

Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and disease

By Ma Qiang  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 10, 2011-10 ,pp. : 1267-1293

Informa Healthcare

Access to resources Recommend Favorite

The Role of Aryl Hydrocarbon Receptor in the Pathogenesis of Cardiovascular Diseases

By Korashy Hesham   El-Kadi Ayman  

Drug Metabolism Reviews, Vol. 38, Iss. 3, 2006-06 ,pp. : 411-450

Informa Healthcare

Access to resources Recommend Favorite